412343003: Cefalexin monohydrate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Cephalosporin (substance)\First generation cephalosporin (substance)\Cefalexin monohydrate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Cephalosporin (substance)\First generation cephalosporin (substance)\Cefalexin monohydrate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Lactam\Beta-lactam (substance)\Substance with beta-lactam structure and antibacterial mechanism of action (substance)\Cephalosporin (substance)\First generation cephalosporin (substance)\Cefalexin monohydrate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cefalexin monohydrate	Is a	Cefalexin	false	Inferred relationship	Some
Cefalexin monohydrate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Cefalexin	true	Inferred relationship	Some
Cefalexin monohydrate	Is a	First generation cephalosporin (substance)	true	Inferred relationship	Some
Cefalexin monohydrate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cefalexin 50mg/mL oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some
Cefalexin 25mg/mL oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some
cefalexin 333 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some
cefalexin 750 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some
Cefalexin 25 mg/mL oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some
cefalexin 500 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some
cefalexin 250 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some
Product containing precisely cefalexin 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some
cefalexin 250 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some
cefalexin 250 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 250 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 500 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 500 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 250 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 250 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 333 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 333 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 750 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 750 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 750 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 333 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 500 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 250 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cefalexin monohydrate	Inferred relationship	Some	1
cefalexin 250 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cefalexin monohydrate	Inferred relationship	Some	1
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cefalexin monohydrate	Inferred relationship	Some	1
Product containing precisely cefalexin (as cefalexin monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cefalexin monohydrate	Inferred relationship	Some	1
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Cefalexin monohydrate	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2473926014	Cephalexin monohydrate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3495261018	Cefalexin monohydrate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3495262013	Cefalexin monohydrate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3483491000005115	cefalexinmonohydrat	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)